A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach

Francesco Lanza; Francesco Saraceni; Annalisa Pezzi; Massimo Martino; Alberto Bosi; Nicola Cascavilla; Pellegrino Musto; Eliana Zuffa; Monica Tani; Claudia Cellini; Daniele Laszlo; Francesca Bonifazi; on behalf of GITMO (Italian Society for Transplantation)

doi:10.1002/ajh.24817

A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach

Francesco Lanza, Francesco Saraceni, Annalisa Pezzi, Massimo Martino, Alberto Bosi, Nicola Cascavilla, Pellegrino Musto, Eliana Zuffa, Monica Tani, Claudia Cellini, Daniele Laszlo, Francesca Bonifazi, on behalf of GITMO (Italian Society for Transplantation)

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	E557-E559
Journal	American Journal of Hematology
Volume	92
Issue number	9
DOIs	https://doi.org/10.1002/ajh.24817
Publication status	Published - Sep 1 2017

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.24817

Cite this

Lanza, F., Saraceni, F., Pezzi, A., Martino, M., Bosi, A., Cascavilla, N., Musto, P., Zuffa, E., Tani, M., Cellini, C., Laszlo, D., Bonifazi, F., & on behalf of GITMO (Italian Society for Transplantation) (2017). A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach. American Journal of Hematology, 92(9), E557-E559. https://doi.org/10.1002/ajh.24817

A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma : a propensity-score weighted multicenter approach. / Lanza, Francesco; Saraceni, Francesco; Pezzi, Annalisa et al.

In: American Journal of Hematology, Vol. 92, No. 9, 01.09.2017, p. E557-E559.

Research output: Contribution to journal › Letter › peer-review

Lanza, F, Saraceni, F, Pezzi, A, Martino, M, Bosi, A, Cascavilla, N, Musto, P, Zuffa, E, Tani, M, Cellini, C, Laszlo, D, Bonifazi, F & on behalf of GITMO (Italian Society for Transplantation) 2017, 'A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach', American Journal of Hematology, vol. 92, no. 9, pp. E557-E559. https://doi.org/10.1002/ajh.24817

@article{b2e7c04fefbe4ff4be5e57ce9af19b2f,

title = "A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach",

author = "Francesco Lanza and Francesco Saraceni and Annalisa Pezzi and Massimo Martino and Alberto Bosi and Nicola Cascavilla and Pellegrino Musto and Eliana Zuffa and Monica Tani and Claudia Cellini and Daniele Laszlo and Francesca Bonifazi and {on behalf of GITMO (Italian Society for Transplantation)}",

year = "2017",

month = sep,

day = "1",

doi = "10.1002/ajh.24817",

language = "English",

volume = "92",

pages = "E557--E559",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "9",

}

TY - JOUR

T1 - A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma

T2 - a propensity-score weighted multicenter approach

AU - Lanza, Francesco

AU - Saraceni, Francesco

AU - Pezzi, Annalisa

AU - Martino, Massimo

AU - Bosi, Alberto

AU - Cascavilla, Nicola

AU - Musto, Pellegrino

AU - Zuffa, Eliana

AU - Tani, Monica

AU - Cellini, Claudia

AU - Laszlo, Daniele

AU - Bonifazi, Francesca

AU - on behalf of GITMO (Italian Society for Transplantation)

PY - 2017/9/1

Y1 - 2017/9/1

UR - http://www.scopus.com/inward/record.url?scp=85025455996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85025455996&partnerID=8YFLogxK

U2 - 10.1002/ajh.24817

DO - 10.1002/ajh.24817

M3 - Letter

AN - SCOPUS:85025455996

VL - 92

SP - E557-E559

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 9

ER -

A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this